Bruce Hellman

Bruce Hellman

CEO & Co-Founder

uMotif

uMotif’s mission is to put patients at the centre of clinical research. Designed with patients for patients, the uMotif patient-centric eClinical platform powers
site-based to fully decentralised clinical, real-world, and post-marketing research. By engaging patients and healthcare professionals, uMotif is trusted by global pharmaceutical companies, biotechs, CROs, and academic institutions to capture eConsent and large volumes of ePRO, symptom, and wearable device data.

More information at www.umotif.com

Other speakers in 2020

Colin Mcguckin

France

Colin McGuckin, Prof. Dr.

Founding Director, Chairman and Chief Scientific Officer
CTI-Biotech Cell Therapy Research Institute, Lyon, France
Dobrin Svinarov

Bulgaria

Prof. Dr. Dobrin Svinarov, MD. PhD, Dr. Med Sc

Head of Clinical Laboratory and Clinical Pharmacology at Alexandrovska University Hospital / Chairman of the Department of Clinical Laboratory and at the Faculty of Medicine, Medical University of Sofia / President of the Bulgarian Society of Clinical laboratory
Skip to content